Senior insider sale
Chief Medical Officer at KALA BIO, INC. — senior position signals high conviction
$39.0K
46.75K shares
What this filing means
BRAZZELL ROMULUS K plans to sell 46.75K shares of KALA BIO, INC. valued at approximately $39.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/22/2025ACC: 0001950047-25-008118
Officer· Chief Medical Officer
Since Jan 2019
46.75K
Shares to sell
$39.0K
Approx. market value
46.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Performance Shares
Not Applicable
10/26/2021
1.10KEmployee Stock Purchase Plan
Cash
6/30/2021
1.22KRestricted Stock
Not Applicable
6/25/2021
40.89KExercised Shares
Cash
4/9/2020
1.35KExercised Shares
Cash
8/11/2017
2.17KTotal acquired46.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2021 | Performance Shares Not Applicable | 1.10K | — |
6/30/2021 | Employee Stock Purchase Plan Cash | 1.22K | — |
6/25/2021 | Restricted Stock Not Applicable | 40.89K | — |
4/9/2020 | Exercised Shares Cash | 1.35K | — |
8/11/2017 | Exercised Shares Cash | 2.17K | — |
| Total | 46.75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
46.75K
Market value
$39.0K
10/22/2025
Total
Units
46.75K
Value
$39.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/22/2025 | 46.75K | $39.0K | NASDAQ | Planned |
| Total | 46.75K | $39.0K | ||